Year

IP Cases — 2024

6,517 decisions across all jurisdictions

By type: patent 5899 trademark 584 copyright 19 design 15

Page 156 of 218 · 6,517 total

patent instituted · Apr 18, 2024

CISCO SYSTEMS, INC. et al. v.InfoExpress Inc.

· IPR2024-00679

Cisco and Fortinet successfully challenged InfoExpress's patent on obviousness grounds in the PTAB. The Board found a reasonable likelihood of prevailing, leading to institution on all 18 asserted claims.

patent instituted · Apr 18, 2024

CISCO SYSTEMS, INC. et al. v.InfoExpress Inc.

· IPR2024-00675

CISCO SYSTEMS and FORTINET successfully convinced the PTAB to institute review against InfoExpress Inc.'s patent, finding a reasonable likelihood of prevailing on multiple claims. The Board adopted a specific claim construction regarding device reconfiguration while accepting the petitioner's obviousness arguments over Krantz and Herrmann.

patent Final Written Decision · Apr 18, 2024

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2024-00790

The PTAB issued a Final Written Decision finding claims 1-3 unpatentable over Kim due to obviousness (103), while claims 4 and 5 were found patentable. The Board construed the key term 'surrounding' as meaning 'all around' or 'encircling.'

patent final · Apr 18, 2024

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2024-00789

The PTAB found claims 1–6 and 11–13 unpatentable over Tessariol, while finding them patentable over Park. The Board's decision hinged on claim construction, specifically defining 'dummy source structure' as one that does not function as a source to memory cells. This outcome significantly impacts the validity of the asserted claims in 3D Memory Devices (NAND).

patent LITIGATION · Apr 17, 2024

Curio Bioscience Inc. v.10x Genomics, Inc.

Luxembourg (LU) · UPC-001532

The Court of Appeal of the Unified Patent Court set aside the order of the President of the Court of First Instance (Local Division Düsseldorf) that had rejected Curio Bioscience's request to change the language of proceedings from German to English. The appeal concerned proceedings in which 10x Genomics sought provisional measures against Curio Bioscience regarding EP 2 697 391. The Court of Appeal held that the lower court's decision was based on an incorrect interpretation of fairness under Article 49(5) EPGÜ and ordered English as the language of proceedings.

patent terminated or settled · Apr 17, 2024

NeoGenomics Laboratories, Inc. v.Natera, Inc.

· IPR2024-00812

NeoGenomics filed an IPR challenging Natera's prenatal‑testing patent. The parties settled before the Board could institute the trial, and the Board granted a joint motion to terminate the proceeding.

patent · Apr 17, 2024

NeoGenomics Laboratories, Inc. v.Natera, Inc.

· IPR2024-00812

NeoGenomics and Natera have filed a joint motion to keep their settlement agreement confidential under 35 U.S.C. § 317(b). The request seeks limited disclosure and asserts no filing fee is due.

patent terminated or settled · Apr 17, 2024

NeoGenomics Laboratories, Inc. v.Natera, Inc.

· IPR2024-00812

NeoGenomics and Natera have settled their dispute over U.S. Patent 11,519,035 and jointly moved to terminate the inter partes review. The Board has not yet decided on institution.

patent · Apr 17, 2024

Qorvo, Inc. v.Cornell Research Foundation Inc.

· IPR2024-00758

Qorvo and Cornell Research Foundation have jointly filed a motion asking the PTAB to treat their settlement agreement as business confidential information under 35 U.S.C. §317(b). The request seeks to keep the agreement separate from the patent file and limit disclosure to parties with good cause.

patent · Apr 17, 2024

Qorvo, Inc. v.Cornell Research Foundation Inc.

· IPR2024-00758

Qorvo (via IQE PLC) petitions the PTAB to invalidate all 24 claims of Cornell’s ’360 epitaxial‑growth patent, asserting obviousness over six prior‑art references under §103. The petition stresses strong discretionary factors favoring institution.

patent terminated or settled · Apr 17, 2024

Qorvo, Inc. v.Cornell Research Foundation Inc.

· IPR2024-00758

Qorvo and Cornell Research Foundation have settled their dispute over U.S. Patent 7,250,360 and jointly moved to terminate the inter partes review. The motion cites 35 U.S.C. § 317(a) and argues that termination aligns with public policy favoring settlements.

patent · Apr 17, 2024

Qorvo, Inc. v.Cornell Research Foundation Inc.

· IPR2024-00758

Court decision.

patent terminated or settled · Apr 17, 2024

Qorvo, Inc. v.Cornell Research Foundation Inc.

· IPR2024-00758

Qorvo and Cornell Research Foundation settled their dispute over U.S. Patent 7,250,360, leading the PTAB to terminate the inter partes review by joint motion. The settlement agreement was ordered kept confidential.

patent null · Apr 17, 2024

Pharaoh Energy Services, LLC v.Flex-Chem Holding Company, LLC et al.

· IPR2024-00815

Pharaoh Energy Services, LLC instituted an IPR against Flex-Chem Holding Company's patent (9944843) concerning Well Stimulation/Acidizing technology. The petition asserts that the claims are invalid under 35 U.S.C. § 102 and § 103 based on prior art references, including Frenier and Reyes.

patent null · Apr 17, 2024

NeoGenomics Laboratories, Inc. v.Natera, Inc.

· IPR2024-00812

NeoGenomics challenges Natera's patent covering cell-free DNA analysis methods in an IPR petition. The petitioner asserts that the claimed method is anticipated or obvious over multiple prior art references, including Forshew and Pieprzyk/May.

patent null · Apr 17, 2024

Qorvo, Inc. v.Cornell Research Foundation Inc.

· IPR2024-00758

Qorvo challenges 24 claims of a semiconductor fabrication patent (7250360) in an IPR petition, asserting that the claimed epitaxial growth and nucleation processes are obvious. The petitioner relies on multiple combinations of prior art references including Urashima, Guo, Nagata, Keiper, and Manabe to demonstrate lack of novelty.

patent denied · Apr 17, 2024

Pharaoh Energy Services, LLC v.Flex-Chem Holding Company, LLC et al.

· IPR2024-00815

The PTAB denied Pharaoh Energy Services' petition to institute IPR proceedings against Flex-Chem for patent 9944843, citing a lack of compelling merits. The Board found that the cumulative weight of Fintiv factors and insufficient technical basis in the petitioner’s evidence led to the denial.

patent dismissed · Apr 16, 2024

V.K.R.Venkatesan Trading as V.K.R. Prakash Modern Rice Mill v.M.Selvanambi Trading as Sri Venkateswara Modern Rice Mills

Madras High Court · 172723642

V.K.R. Venkatesan filed a civil suit against M. Selvanambi, alleging infringement of his 'SIVAJI BRAND' trademark and copyright violation concerning rice packaging. The original prayer sought permanent injunctions, damages, and accounting of profits due to the defendant's use of similar marks and labels. However, on April 16, 2024, the court noted that the plaintiff's counsel had requested withdrawal of the suit, leading to its dismissal.

trademark interim order · Apr 16, 2024

Regency Plywood Industries Pvt. Ltd v.Chowdhury Enterprise And Ors

Calcutta High Court · 73749957

The plaintiff filed a suit seeking relief concerning its registered mark "METRO" against the respondents. The court addressed procedural matters, granting the plaintiff leave to add prayers and confirming jurisdiction under specific legal provisions.

patent pending · Apr 16, 2024

Alcon Inc v.Controller Of Patents And Designs

Delhi High Court - Orders · 47474816

Alcon Inc filed an appeal before the Delhi High Court challenging the Assistant Controller's decision to refuse the grant of its Indian Patent Application No. 201914027377. The court issued notice and directed both parties to file written submissions, setting a date for re-notification.

patent pending · Apr 16, 2024

Oxular Limited v.The Assistant Controller of Patents and Designs

Delhi High Court - Orders · 108832237

Oxular Limited appealed against the Assistant Controller's refusal to grant an Indian Patent Application (No. 201817034819). The appellant argued that the invention disclosed a substantial technical advancement and economic significance, fulfilling the necessary criteria.

patent pending · Apr 16, 2024

Medilabo Rfp Inc v.The Controller Of Patents

Delhi High Court - Orders · 32138602

Medilabo Rfp Inc filed an appeal challenging the Assistant Controller's refusal of its patent application (no. 202117034705) under Section 3(i) of the Patents Act, 1970. The court first condoned a delay of 12 days in filing the appeal and subsequently issued notice to the respondent for submission.

patent pending · Apr 16, 2024

Immunovative Therapies, Ltd v.The Controller Of Patents

Delhi High Court - Orders · 46116651

Immunovative Therapies, Ltd filed an appeal against objections raised by The Controller of Patents. The respondent completed submissions on Sections 10(4) and 3(i) of the Patents Act, 1970, requesting a hearing regarding objections under Sections 2(1)(ja) and 3(d).

patent plaintiff favorable · Apr 16, 2024

Microsoft Technology Licensing, Llc v.Assistant Controller Of Patents And Designs

Delhi High Court · 30117331

Microsoft Technology Licensing, LLC appealed a refusal by the Assistant Controller of Patents to grant a patent titled 'Reversible 2-Dimensional Pre-/Post-Filtering for Lapped Biorthogonal Transform'. The refusal was based on Section 3(k) of the Patents Act, 1970. The High Court ultimately held that the invention provided tangible benefits beyond ordinary computing functionality and was therefore patentable.

trademark dismissed · Apr 16, 2024

V.Lakshminarayanasamy & Suguna Lakshminarayanasamy v.Siva Bhaskaren & The Deputy Registrar, Trademark Registry, Chennai

Madras High Court · 66738257

The Madras High Court dismissed a petition seeking the removal or cancellation of Trademark Registration No. 1191299, which was registered in Siva Bhaskaren's name for goods like pressure cookers and fans. The court noted that the trademark's validity expired on April 10, 2023, as no renewal request had been filed within the ten-year period. Consequently, the petition seeking rectification became infructuous, leading to its closure.

patent LITIGATION · Apr 15, 2024

Advanced Bionics AG, Advanced Bionics GmbH, and Advanced Bionics Sarl v.MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.

Mannheim (DE) Local Division · UPC-001533

This order concerns an application by the defendants (Advanced Bionics entities) to change the language of proceedings from German to English in an infringement action brought by MED-EL regarding European Patent EP4074373 ('MRI-safe disk magnet for implants'). The President of the Court of First Instance declared the application admissible but rejected it on the merits, finding that the circumstances cited by the defendants resulted from their own strategic choices and did not demonstrate significant disadvantage justifying a change of language.

patent terminated or settled · Apr 15, 2024

The Integration Group of Americas, Inc. v.SitePro, Inc.

· IPR2024-00737

The Integration Group of Americas and SitePro entered a settlement that resolves all disputes over U.S. Patent No. 11,756,680 and jointly moved to terminate the pending IPR.

patent terminated or settled · Apr 15, 2024

The Integration Group of America, Inc. v.SitePro, Inc.

· IPR2024-00724

The Integration Group of Americas and SitePro settled their dispute over U.S. Patent 8,649,909, leading the PTAB to terminate the IPR before trial.

patent terminated or settled · Apr 15, 2024

The Integration Group of Americas, Inc. v.SitePro, Inc.

· IPR2024-00740

The Integration Group and SitePro settled their dispute over U.S. Patent 11,726,504 B2 before the IPR was instituted, leading the PTAB to terminate the proceeding.

patent terminated or settled · Apr 15, 2024

The Integration Group of Americas, Inc. v.SitePro, Inc.

· IPR2024-00739

The Integration Group of Americas and SitePro settled their IPR dispute over patent 9,898,014, leading the PTAB to terminate the proceeding before trial.

Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →